LONG-TERM ADMINISTRATION OF INTRAVENOUS IMMUNOGLOBIN (IVIG) TO PREVENT LATE INFECTION AND CHRONIC GRAFT-VERSUS-HOST DISEASE (GVHD) FOLLOWING MARROW TRANSPLANTATION - CLINICAL OUTCOME AND EFFECT ON SUBSEQUENT IMMUNE RECOVERY
Km. Sullivan et al., LONG-TERM ADMINISTRATION OF INTRAVENOUS IMMUNOGLOBIN (IVIG) TO PREVENT LATE INFECTION AND CHRONIC GRAFT-VERSUS-HOST DISEASE (GVHD) FOLLOWING MARROW TRANSPLANTATION - CLINICAL OUTCOME AND EFFECT ON SUBSEQUENT IMMUNE RECOVERY, Blood, 86(10), 1995, pp. 1824-1824